Galecto
IPORedefining care for people with blood disorders
Galecto is a biotech company in Copenhagen, Denmark, founded in 2010. It has raised $446.9M across 4 rounds, most recently a $285.0M Series C in November 2025.
- Headquarters
- Copenhagen, Capital Region
- Employees
- 11–50
- Founded
- 2010
- Business Model
- B2B
- Website
- galecto.com
- Total Funding
- $446.9M
- Last Round
- $285.0M Series CNov 2025
- Rounds
- 4
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 4 funding rounds and 12 investors for this company. to use credits for reveals, or explore the API.
About
Galecto is a clinical-stage biopharmaceutical company developing small-molecule and antibody therapeutics targeting galectin proteins for the treatment of fibrosis, cancer, and hematologic disorders. Its pipeline includes programs for idiopathic pulmonary fibrosis and myeloproliferative neoplasms. In March 2026 the company announced a name change to Damora Therapeutics following its acquisition of Damora Therapeutics and a strategic pivot to mutant calreticulin-driven blood disorders.
Funding & Exit History
Nov 2025
4 more events
- IPO2020
- Series D20204 investors
- Series C20187 investors
Funding: Pre-Seed through Series C. Amounts, valuations, and investors where available.
Investors
Soleus Capital
1 round
Ysios Capital
1 round
OrbiMed
1 round
Novo Nordisk Foundation
1 round
EIR Ventures
1 round
Cormorant Asset Management
1 round
Janus Fund
1 round
HBM Healthcare Investments
1 round
Bristol Myers Squibb
1 round
Maverick Ventures
1 round
Seventure Partners
1 round
Novo Holdings A/S
1 round
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
- Cloud/Infrastructure ×1
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Companies in related industries

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/galecto"><img src="https://indexed.vc/api/badge/company/galecto" alt="Galecto on Indexed.vc" width="260" height="76" /></a>